A detailed history of Hosking Partners LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Hosking Partners LLP holds 62,110 shares of BIO stock, worth $19.9 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
62,110
Previous 65,066 4.54%
Holding current value
$19.9 Million
Previous $17.8 Million 16.94%
% of portfolio
0.83%
Previous 0.68%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$263.97 - $344.64 $780,295 - $1.02 Million
-2,956 Reduced 4.54%
62,110 $20.8 Million
Q2 2024

Jul 29, 2024

SELL
$268.26 - $339.48 $1.06 Million - $1.34 Million
-3,941 Reduced 5.71%
65,066 $17.8 Million
Q1 2024

May 02, 2024

SELL
$304.11 - $351.99 $65,079 - $75,325
-214 Reduced 0.31%
69,007 $23.9 Million
Q4 2023

Feb 13, 2024

SELL
$269.37 - $365.04 $1.35 Million - $1.83 Million
-5,005 Reduced 6.74%
69,221 $22.4 Million
Q3 2023

Nov 08, 2023

BUY
$350.25 - $422.63 $1.24 Million - $1.49 Million
3,535 Added 5.0%
74,226 $26.6 Million
Q2 2023

Aug 02, 2023

BUY
$359.49 - $486.4 $6.61 Million - $8.95 Million
18,401 Added 35.19%
70,691 $26.8 Million
Q1 2023

May 09, 2023

SELL
$418.69 - $503.0 $4.51 Million - $5.41 Million
-10,762 Reduced 17.07%
52,290 $25 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $5.03 Million - $6.52 Million
14,294 Added 29.32%
63,052 $26.5 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $1.36 Million - $1.86 Million
-3,306 Reduced 6.35%
48,758 $20.3 Million
Q2 2022

Aug 04, 2022

SELL
$463.67 - $597.16 $4.77 Million - $6.14 Million
-10,282 Reduced 16.49%
52,064 $25.8 Million
Q1 2022

May 05, 2022

SELL
$524.57 - $735.42 $733,873 - $1.03 Million
-1,399 Reduced 2.19%
62,346 $35.1 Million
Q4 2021

Feb 04, 2022

SELL
$708.84 - $794.68 $868,329 - $973,482
-1,225 Reduced 1.89%
63,745 $48.2 Million
Q3 2021

Nov 09, 2021

SELL
$657.71 - $825.77 $5.2 Million - $6.53 Million
-7,903 Reduced 10.84%
64,970 $48.5 Million
Q2 2021

Aug 03, 2021

SELL
$576.64 - $649.04 $579,523 - $652,285
-1,005 Reduced 1.36%
72,873 $47 Million
Q1 2021

May 10, 2021

SELL
$547.01 - $662.35 $1.55 Million - $1.87 Million
-2,827 Reduced 3.69%
73,878 $42.2 Million
Q4 2020

Feb 05, 2021

SELL
$510.68 - $643.45 $1.37 Million - $1.73 Million
-2,685 Reduced 3.38%
76,705 $44.7 Million
Q3 2020

Nov 09, 2020

SELL
$454.43 - $535.6 $1.27 Million - $1.5 Million
-2,796 Reduced 3.4%
79,390 $40.9 Million
Q2 2020

Aug 05, 2020

SELL
$334.87 - $493.06 $2.02 Million - $2.98 Million
-6,038 Reduced 6.84%
82,186 $37.1 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $952,669 - $1.22 Million
-2,977 Reduced 3.26%
88,224 $30.9 Million
Q4 2019

Feb 06, 2020

SELL
$319.73 - $374.2 $1.17 Million - $1.37 Million
-3,673 Reduced 3.87%
91,201 $33.7 Million
Q3 2019

Nov 13, 2019

SELL
$304.55 - $345.24 $1.45 Million - $1.64 Million
-4,748 Reduced 4.77%
94,874 $31.6 Million
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $208,598 - $227,252
-727 Reduced 0.72%
99,622 $31.1 Million
Q1 2019

May 08, 2019

SELL
$224.3 - $317.41 $113,271 - $160,292
-505 Reduced 0.5%
100,349 $30.7 Million
Q4 2018

Feb 11, 2019

BUY
$220.1 - $309.0 $889,424 - $1.25 Million
4,041 Added 4.17%
100,854 $23.4 Million
Q3 2018

Nov 13, 2018

SELL
$289.28 - $326.15 $728,117 - $820,919
-2,517 Reduced 2.53%
96,813 $30.3 Million
Q2 2018

Aug 13, 2018

BUY
$244.1 - $303.88 $142,066 - $176,858
582 Added 0.59%
99,330 $28.7 Million
Q1 2018

May 10, 2018

BUY
$233.97 - $274.11 $1.01 Million - $1.18 Million
4,304 Added 4.56%
98,748 $24.7 Million
Q4 2017

Feb 08, 2018

BUY
$216.94 - $271.3 $1.43 Million - $1.79 Million
6,586 Added 7.5%
94,444 $22.5 Million
Q3 2017

Nov 09, 2017

BUY
$212.27 - $242.28 $78,752 - $89,885
371 Added 0.42%
87,858 $19.5 Million
Q2 2017

Aug 09, 2017

BUY
N/A
87,487
87,487 $19.8 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Hosking Partners LLP Portfolio

Follow Hosking Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hosking Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Hosking Partners LLP with notifications on news.